C12N 2500/30
Organic components
C12N2500/30 (Organic components) appears on 2,151 US grants and 4,052 published applications in this corpus.
Search patents in C12N- Granted patents
- 2,151
- Published applications
- 4,052
- Assignees
- 1,804
- Inventors
- 7,754
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 4 | 0 |
| 1989 | 5 | 0 |
| 1990 | 2 | 0 |
| 1991 | 7 | 0 |
| 1992 | 13 | 0 |
| 1993 | 5 | 0 |
| 1994 | 13 | 0 |
| 1995 | 12 | 0 |
| 1996 | 18 | 0 |
| 1997 | 27 | 0 |
| 1998 | 38 | 0 |
| 1999 | 38 | 0 |
| 2000 | 33 | 0 |
| 2001 | 31 | 15 |
| 2002 | 35 | 67 |
| 2003 | 30 | 74 |
| 2004 | 27 | 71 |
| 2005 | 27 | 101 |
| 2006 | 34 | 90 |
| 2007 | 22 | 88 |
| 2008 | 36 | 89 |
| 2009 | 32 | 96 |
| 2010 | 45 | 123 |
| 2011 | 49 | 121 |
| 2012 | 60 | 106 |
| 2013 | 60 | 129 |
| 2014 | 80 | 115 |
| 2015 | 91 | 169 |
| 2016 | 111 | 172 |
| 2017 | 100 | 191 |
| 2018 | 106 | 196 |
| 2019 | 107 | 228 |
| 2020 | 133 | 253 |
| 2021 | 97 | 270 |
| 2022 | 122 | 272 |
| 2023 | 129 | 301 |
| 2024 | 127 | 291 |
| 2025 | 133 | 250 |
| 2026 | 100 | 174 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2500/38VitaminsIndexing code803
- C12N 2500/32Amino acidsIndexing code660
- C12N 2500/34SugarsIndexing code555
- C12N 2500/36LipidsIndexing code333
- C12N 2500/44ThiolsIndexing code239
- C12N 2500/46AminesIndexing code227
- C12N 2500/40Nucleotides, nucleosides or basesIndexing code143
- C12N 2500/42Organic phosphateIndexing code95
All 9 subgroupsShow fewer
Recent patents
- Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke6 Oct 2026US 12,751,976 B2The Regents of the University of California
- Method for producing cell sheet6 Oct 2026US 12,753,390 B2Kaneka Corporation
- Application of alkali-tolerant microbial bacteria PDC-1 and its in-situ remediation of organic contaminated soil in mining areas22 Sep 2026US 12,742,148 B2Chinese Research Academy of Environmental Sciences
- Compositions and methods for increasing T cell function15 Sep 2026US 12,734,150 B2Ludwig Institute for Cancer Research
- Cellulose constructs based on gas vesicles and bacterial cellulose15 Sep 2026US 12,735,674 B1
- Production of a probiotic composition8 Oct 2026US 2026/0306558 A1Blis Technologies Limited
- Metabolically enhanced vd1 t cells and uses thereof8 Oct 2026US 2026/0308518 A1
- In vitro culturing method for inducing ovarian follicles from fetal ovarian cells of primate8 Oct 2026US 2026/0308531 A1Kyoto University
- Micropattern-assisted generation of tissue8 Oct 2026US 2026/0308533 A1
- Method for the Production of Pharmaceutically Active Recombinant Human Low Molecular Weight Urokinase8 Oct 2026US 2026/0308654 A1Cerbios-Pharma SA
Most cited
By later US patents
- Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration549US 6,200,606 B1DePuy Orthopaedics, Inc. · 2001
- Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins500US 5,122,469 AGenentech, Inc. · 1992
- Technique for healing lesions in cartilage498US 4,846,835 A1989
- Protein-free culture medium464US 4,767,704 AColumbia University in the City of New York · 1988
- Serum-free, synthetic, completely chemically defined tissue culture media450US 4,657,866 A1987